ArticleBlood cancer discovery2021

Employing Synthetic T-cell Biology to Target AML without On-Target/Off-Cancer Toxicity.

M Paulina Velasquez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.